新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122)-蛋白质/抗原/多肽-试剂-生物在线
新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122)

新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122)

商家询价

产品名称： 新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122)

英文名称： Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122)

产品编号： SPD-M162

产品价格： 0

产品产地： USA

品牌商标： ACROBiosystems

更新时间： null

使用范围： null

北京百普赛斯生物科技股份有限公司
  • 联系人 :
  • 地址 : 北京经济技术开发区宏达北路8号5号楼4层
  • 邮编 : 100176
  • 所在区域 : 北京
  • 电话 :
  • 传真 :
  • 邮箱 : order.cn@acrobiosystems.com
进入展台 

Anti-SARS-CoV-2 Spike RBD Neutralizing antibody, Human IgM (SPD-M162) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).
Isotype
IgM/kappa
Specificity
This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain.  No cross-reactivity is detected with Spike protein RBD domain of other coronaviruses, including SARS-CoV,  MERS-CoV,  HCoV-229E,HCoV-NL63,HCoV-OC43 and HCoV-HKU1.
Purity
>95% as determined by SDS-PAGE.
Bioactivity